De Groene WEG SRL
De Groene WEG reported total assets of 189,429 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jun 2026).
The score of De Groene WEG shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +800 % Total assets -31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Groene WEG's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 09 Jun 2022
De Groene WEG's financial analysis
- Solvency7.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Groene WEG
De Groene WEG's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0472.529.857
- VAT number
- BE0472529857
- Peppol
- Registered · 0208:0472529857 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Aug 2000
- Registered office
- 2520 Ranst
- Latest accounts
- 2025 · filed on 03 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
De Groene WEG (SRL) has been based in Ranst since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 10,209 € and equity of 13,771 €; its revenue is not published. Its solvency stands at 7.3%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De Groene WEG
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- White-to-Black Retail sale of pharmaceutical products Dilbeek · balance sheet 209,334 €
- D-Pharma Retail sale of pharmaceutical products Brasschaat · balance sheet 226,463 €
- Sarina Janssens Farma Retail sale of pharmaceutical products Bierbeek · balance sheet 136,654 €
- Farmafender Retail sale of pharmaceutical products Zedelgem · balance sheet 269,880 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
- Liwoma Retail sale of pharmaceutical products Kontich · balance sheet 289,010 €
Frequently asked questions about De Groene WEG
What is the revenue of De Groene WEG?
De Groene WEG files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De Groene WEG?
In Belgium, the VAT number is the company number prefixed with BE: BE0472529857 for De Groene WEG, if the company is VAT-registered. Its company number (CBE) is 0472.529.857.
Where is the registered office of De Groene WEG?
According to the CBE register, the registered office of De Groene WEG is in 2520 Ranst.
What is the equity of De Groene WEG?
At the close of the 2025 financial year, the equity of De Groene WEG amounts to 13,771 €, a solvency of 7.3% of total assets.
Who manages De Groene WEG?
The register lists 1 active mandates at De Groene WEG. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De Groene WEG
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →